title: Possible cyclosporin-danazol interaction in a patient with aplastic anaemia.
authors.forename: J
authors.initials: J
authors.lastname: Borrás-Blasco
authors.forename: J D
authors.initials: JD
authors.lastname: Rosique-Robles
authors.forename: J
authors.initials: J
authors.lastname: Peris-Marti
authors.forename: J
authors.initials: J
authors.lastname: Navarro-Ruiz
authors.forename: M
authors.initials: M
authors.lastname: Gonzalez-Delgado
authors.forename: V
authors.initials: V
authors.lastname: Conesa-Garcia
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000188:drug therapy*; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D065607:Cytochrome P-450 Enzyme Inhibitors; D003613:Danazol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D016903:Drug Monitoring; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D008658:Inactivation, Metabolic; D008297:Male
chemical_list: D065607:Cytochrome P-450 Enzyme Inhibitors; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003613:Danazol